查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
免疫谱库测序市场：按产品类型,按应用,按国家,按地区-行业分析,市场规模,市场份额,2023-2030 年预测
市场调查报告书
商品编码
1290857

免疫谱库测序市场：按产品类型,按应用,按国家,按地区-行业分析,市场规模,市场份额,2023-2030 年预测

Immune Repertoire Sequencing Market with COVID-19 Impact Analysis, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年免疫谱库测序市场规模将达到13.158亿美元，2023年至2030年復合年增长率为7.7%

免疫库测序市场 - 市场动态

政府加大对基于药物基因组学的药物召回的支持预计将推动市场需求

免疫组库测序可以通过提供对患者免疫系统和对药物治疗的反应的额外了解来促进药物基因组学。例如，在癌症治疗方面，免疫组库测序有助于识别免疫系统识别的肿瘤特异性抗原。然而，针对癌症和其他传染病的免疫疗法的需求不断增加预计将推动免疫库测序市场的增长。免疫治疗药物在某些癌症中比其他癌症效果更好，对某些患者来说可能是一个奇蹟，但并非对所有人来说都是奇蹟。总体回復率约为15-20%。此外，根据约翰霍普金斯医学的数据，癌症免疫治疗有自己的股票指数，由25家价值超过1亿美元的公司组成。

免疫组库测序市场 - 关键见解

  • 由于可持续增长意识的增强，免疫库测序行业预计将大幅增长
  • 按产品类型划分，检测试剂盒预计将在 2022 年占据最大的市场份额
  • 从应用来看，癌症免疫治疗是2022年的主要类型。
  • 按地区划分，北美是2022年的主要收入来源。

免疫组库测序市场细分分析：

全球免疫组库测序市场根据产品类型,应用,技术和地区进行细分。

根据产品类型，市场分为三类：仪器和检测试剂盒。检测试剂盒可能会主导市场。这些试剂盒通常包括用于样品製备,文库构建,测序和数据分析的试剂和方案。

市场按应用分为六类：癌症免疫治疗,生物标誌物发现,自身免疫性疾病,疫苗开发和功效,移植排斥和耐受,传染病和其他。癌症免疫疗法在市场上占据主导地位，并将在预测期内保持其主导地位。癌症免疫疗法是一个快速发展的领域，利用人体的免疫系统来对抗癌症。

免疫库测序市场 - 地理洞察

从地域上看，该市场遍布北美,拉丁美洲,欧洲,亚太,中东和非洲地区。这些地区根据引入业务的国家进一步划分。由于政府为改善医疗基础设施提供的资金不断增加，预计北美将主导免疫组库测序市场的增长。在医疗健康研发方面，联邦政府投资占美国所有医疗健康研发的四分之一（25%），为615亿美元，仅美国国立卫生研究院（NIH）就占这一数字，2020年将占20占所有此类投资的%（489 亿美元）。在这个层面上，美国国立卫生研究院是仅次于生物製药行业的第二大医疗健康研究资助者。然而，增加政府资助可以为研究人员和机构提供资源来开展免疫组库测序研究。由于研发和新产品发布的增加，欧洲和亚太地区预计在预测期内将大幅增长。

免疫谱库测序市场-竞争格局：

对免疫组库测序的需求正在稳步增长，因为它在阐明免疫系统,疾病进展和开发个性化疗法方面发挥着关键作用。每家公司都提供用于免疫谱分析的测序仪器,试剂和软件解决方案。免疫组库测序市场竞争激烈，各个公司和研究机构都在推动创新并提供免疫组库测序和分析的解决方案。测序技术,生物信息学工具和数据分析方法的进步继续塑造竞争格局并促进市场的增长。例如，Thermofisher宣布，将于 2023 年推出新的 Ion Torrent Oncomine 免疫组库检测系列，旨在检测在免疫反应系统中发挥关键作用的 T 细胞和 B 细胞的潜在恶性克隆。

近期动向

Pfizer和Adaptive Biotechnologies Corporation启动了一项转化研究合作，利用适应性免疫系统的下一代测序来推进辉瑞不断增长的免疫肿瘤学特许经营权。根据协议，Pfizer和 Adaptive 寻求将药物开发和平台技术方面的生物标誌物专业知识结合起来，以确定可能优先受益于免疫治疗的患者。

研究的主要特点

  • 本研究报告以2022年为基准年，提供了免疫谱库测序市场的市场规模,复合年增长率（CAGR%）,估计和预测（2023-2030年）。
  • 该研究报告为客户提供了免疫谱库测序市场的最新趋势见解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并说明了免疫谱库测序市场有吸引力的投资主张矩阵。
  • 总体报告确定了新的投资机会,现有企业面临的挑战以及免疫组库测序市场可持续发展的增长动力。
  • COVID-19 对免疫谱库测序市场规模,预测,复合年增长率和市场动态的影响将在研究范围下详细讨论。它还涵盖了对新冠疫情后免疫库测序市场的深入见解。
  • 为了向本报告的用户提供免疫组库测序市场的全面了解，还包括免疫组库测序市场的竞争格局和关键创新者分析。
  • 该研究涵盖了基于市场规模,增长率和吸引力对所有行业领域进行基准测试的增长前景映射分析。
  • 它提供了主要市场进入者的详细公司简介，以帮助您了解免疫谱库测序市场中运营公司的财务信息和战略举措。
  • 此外，报告还揭示了全球和区域市场主要进入者的重大收购和兼併,联盟和合资企业,新产品推出,研发和区域扩张。
  • 免疫谱库测序全球市场报告主要面向该行业的各个利益相关者，如供应商,投资者,新进入者,分销商和财务分析师。

目录

第一章 免疫组库测序市场概述

  • 调查范围

第二章执行摘要

  • 市场细分
  • 竞争考虑

第 3 章 免疫谱测序的主要市场趋势

  • 免疫组库测序的市场驱动因素
  • 免疫组库测序市场製约因素
  • 免疫组库测序的市场机会
  • 免疫组库测序市场未来趋势

第四章 免疫库测序行业概况

  • PEST分析
  • 波特五力分析
  • 绘製增长前景
  • 监管框架分析

第五章免疫库测序市场：COVID-19疾病的影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后的影响分析

第六章 免疫组库测序市场格局

  • 2022 年免疫谱库测序市场份额分析
  • 主要製造商的细分数据
    • 已成立公司分析
    • 启动分析

7 免疫谱库测序市场-按产品类型

  • 概述
    • 按产品类型划分的细分市场份额分析
    • 机器
    • 检测试剂盒

8 免疫谱库测序市场——按应用分类

  • 概述
    • 按应用划分的细分市场份额分析
    • 癌症免疫治疗
    • 生物标誌物发现
    • 自身免疫性疾病
    • 疫苗开发和功效
    • 移植排斥和耐受
    • 感染
    • 其他

9 免疫谱库测序市场-按地区

  • 介绍
  • 北美
    • 概述
    • 北美领先的免疫组库测序製造商
    • 美国
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲领先的免疫组库测序製造商
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 其他
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区领先的免疫组库测序製造商
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印度尼西亚
    • 菲律宾
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲领先的免疫组库测序製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他
  • 中东和非洲
    • 概述
    • 中东和非洲领先的免疫组库测序製造商
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他

第十章 免疫组库测序行业重点厂商分析

  • 比赛仪表板
  • 公司简介
    • Illumina Inc.
    • Thermo Fisher Scientific
    • PacBio
    • CD Genomics
    • Agilent Technologies, Inc
    • F. Hoffmann-La Roche Ltd
    • BGI Group Guangdong
    • Takara Bio, Inc.
    • Adaptive Biotechnologies
    • Juno Therapeutics
    • Atreca, Inc.
    • irepertoire, Inc.

第十一章 分析师的全面看法

Product Code: ANV1311

REPORT HIGHLIGHT

Immune Repertoire Sequencing Market size was valued at USD 1,315.8 million in 2022, expanding at a CAGR of 7.7% from 2023 to 2030.

Immune repertoire sequencing is a technique used to analyze the diversity and composition of the immune system's repertoire of antibodies or T cell receptors. Immune repertoire refers to all of the unique T-cell receptor and B-cell receptor genetic rearrangements within the adaptive immune system It has unique advantages compared to the more common diagnostic and prognostic techniques that predate it. The traditional strategies for studying the immune repertoire, which include spectating, Sanger sequencing et al., are laborious, costly, and insufficient for generating a high-resolution picture of the immune repertoire. For instance, specific disease prognoses can lead to the evolution of similar or identical CDR3s in different patients. CDR3 sequencing can thus potentially be used for diagnosis.

Immune Repertoire Sequencing Market- Market Dynamics

An increase in government support for pharmacogenomics-based drug recovery is expected to propel market demand

Immune repertoire sequencing can accessory pharmacogenomics by providing additional acumens into a patient's immune system and its response to drug therapies. For example, in the perspective of cancer treatment, immune repertoire sequencing can help identify tumor-specific antigens recognized by the immune system. However, the increase in demand for immunotherapy for cancer and other infectious diseases is expected to propel the growth of the Immune Repertoire Sequencing Market. Immunotherapy drugs work better in some cancers than others and while they can be a miracle for some, they fail to work for all patients. Overall response rates are about 15 to 20%. And also there is so much pharmaceutical R&D that cancer immunotherapy has its own stock index of 25 companies worth USD100 million or more, according to Johns Hopkins Medicine.

Immune Repertoire Sequencing Market- Key Insights

  • As per the analysis shared by our research analyst, the global Immune Repertoire Sequencing market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
  • The Immune Repertoire Sequencing industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on product type segmentation, Assay Kits was predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Cancer Immunotherapy was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Immune Repertoire Sequencing Market- Segmentation Analysis:

The Global Immune Repertoire Sequencing Market is segmented on the basis of Product Type, Application, Technology, and Region.

The market is divided into three categories based on product type: Instruments and Assay Kits. Assay Kits are likely to dominate the market. These kits typically include reagents and protocols for sample preparation, library construction, sequencing, and data analysis.

The market is divided into six categories based on application: Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development and Efficacy, Transplant Rejection, and Tolerance, Infectious Diseases, and Others. Cancer Immunotherapy dominates the market and is likely to maintain its dominance during the forecast period. Cancer immunotherapy is a rapidly advancing field that utilizes the body's immune system to fight cancer.

Immune Repertoire Sequencing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Immune Repertoire Sequencing Market, due to rising Government Funding to Improve the Healthcare Infrastructure. Medical and Health Research and Development predicted that the Federal government investment accounts for one-quarter (25%) of all U.S. medical and health R&D at USD61.5 billion, with the National Institutes of Health (NIH) alone accounting for 20% (USD48.9 billion) of all such investment in 2020. At this level, NIH is the second largest funder of medical and health research after the biopharmaceutical industry. However, Increased government funding can provide researchers and institutions with more resources to conduct research on immune repertoire sequencing. Europe and the Asia Pacific are expected to expand significant growth during the forecast period, due to increasing research and development and launches of novel products.

Immune Repertoire Sequencing Market- Competitive Landscape:

The demand for immune repertoire sequencing has been steadily increasing due to its vital role in understanding the immune system, disease progression, and developing personalized therapies. The companies provide sequencing instruments, reagents, and software solutions for immune repertoire analysis. The immune repertoire sequencing market is competitive, with a range of companies and research institutions driving innovation and providing solutions for sequencing and analyzing immune repertoires. Advancements in sequencing technologies, bioinformatics tools, and data analysis methods continue to shape the competitive landscape and contribute to the growth of the market. For example, in 2023, Thermo Fisher Scientific announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T-cells and B-cells, which play a key role in the immune response system.

Recent Developments:

Pfizer Inc. and Adaptive Biotechnologies Corporation have entered into a translational research collaboration to leverage next-generation sequencing of the adaptive immune system to advance Pfizer's growing immuno-oncology franchise. Under the terms of the agreement, Pfizer and Adaptive will seek to combine drug development and platform technology biomarker expertise to identify patients who may preferentially benefit from immunotherapy.

Key features of the study:

  • This proposed research study on Immune Repertoire Sequencing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Immune Repertoire Sequencing market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Immune Repertoire Sequencing market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Immune Repertoire Sequencing market
  • Impact of COVID-19 on Immune Repertoire Sequencing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Immune Repertoire Sequencing market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Immune Repertoire Sequencing market, we have also included competitive landscape and key innovator analysis for the Immune Repertoire Sequencing market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Immune Repertoire Sequencing market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Immune Repertoire Sequencing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET KEY PLAYERS

  • Illumina Inc.
  • Thermo Fisher Scientific
  • PacBio
  • CD Genomics
  • Agilent Technologies, Inc
  • F. Hoffmann-La Roche Ltd
  • BGI Group Guangdong
  • Takara Bio, Inc.
  • Adaptive Biotechnologies
  • Juno Therapeutics
  • Atreca, Inc.
  • irepertoire, Inc.

GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT TYPE

  • Instruments
  • Assay Kits

GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION

  • Cancer Immunotherapy
  • Biomarker Discovery
  • Autoimmune Diseases
  • Vaccine Development and Efficacy
  • Transplant Rejection and Tolerance
  • Infectious Diseases
  • Others

GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Immune Repertoire Sequencing Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immune Repertoire Sequencing Market Snippet by Product Type
    • 2.1.2. Immune Repertoire Sequencing Market Snippet by Application
    • 2.1.3. Immune Repertoire Sequencing Market Snippet by Country
    • 2.1.4. Immune Repertoire Sequencing Market Snippet by Region
  • 2.2. Competitive Insights

3. Immune Repertoire Sequencing Key Market Trends

  • 3.1. Immune Repertoire Sequencing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immune Repertoire Sequencing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immune Repertoire Sequencing Market Opportunities
  • 3.4. Immune Repertoire Sequencing Market Future Trends

4. Immune Repertoire Sequencing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immune Repertoire Sequencing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Immune Repertoire Sequencing Market Landscape

  • 6.1. Immune Repertoire Sequencing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immune Repertoire Sequencing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Instruments
    • 7.1.3. Assay Kits

8. Immune Repertoire Sequencing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Cancer Immunotherapy
    • 8.1.3. Biomarker Discovery
    • 8.1.4. Autoimmune Diseases
    • 8.1.5. Vaccine Development and Efficacy
    • 8.1.6. Transplant Rejection and Tolerance
    • 8.1.7. Infectious Diseases
    • 8.1.8. Others

9. Immune Repertoire Sequencing Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Immune Repertoire Sequencing Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Immune Repertoire Sequencing Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Immune Repertoire Sequencing Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Immune Repertoire Sequencing Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Immune Repertoire Sequencing Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Immune Repertoire Sequencing Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Illumina Inc.
    • 10.2.2. Thermo Fisher Scientific
    • 10.2.3. PacBio
    • 10.2.4. CD Genomics
    • 10.2.5. Agilent Technologies, Inc
    • 10.2.6. F. Hoffmann-La Roche Ltd
    • 10.2.7. BGI Group Guangdong
    • 10.2.8. Takara Bio, Inc.
    • 10.2.9. Adaptive Biotechnologies
    • 10.2.10. Juno Therapeutics
    • 10.2.11. Atreca, Inc.
    • 10.2.12. irepertoire, Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Immune Repertoire Sequencing Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Immune Repertoire Sequencing Market, by Product Type 2018-2030 (USD Million)
  • TABLE Immune Repertoire Sequencing Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Immune Repertoire Sequencing Market, by Application 2018-2030 (USD Million)
  • TABLE Immune Repertoire Sequencing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Immune Repertoire Sequencing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Immune Repertoire Sequencing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE Europe Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE Asia Pacific Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE Latin America Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE Middle East and Africa Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Immune Repertoire Sequencing Market share analysis by country, 2022
  • FIGURE Germany Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Immune Repertoire Sequencing Market share analysis by country, 2022
  • FIGURE India Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Immune Repertoire Sequencing Market share analysis by country, 2022
  • FIGURE Brazil Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Immune Repertoire Sequencing Market share analysis by country, 2022
  • FIGURE Saudi Arabia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)